BioSpace News Archive

Deals

Achieve Life Sciences to Announce First Quarter 2019 Financial Results and Host Conference Call and Webcast on May 15, 2019

Achieve Life Sciences, Inc. announced that it will report its first quarter 2019 financial results on Wednesday, May 15, 2019.

May 7, 2019
·
1 min read
Deals

Mallinckrodt plc Reports Strong Growth in First Quarter 2019 Results, Raises Guidance for 2019, and Continues to Make Significant Advancements in Pipeline and Data Generation

Net sales up 4.7%, or 5.0% on a constant-currency basis, on $790.6 million, led by strong performance of hospital products and the Specialty Generics and Amitiza segment

May 7, 2019
·
14 min read
BioForest

QuoteWizard Study Finds the Fittest and Fattest States in America

QuoteWizard®, a LendingTree company, and one of the nation’s leading online insurance marketplaces, conducted a study that found the fittest and fattest states in America.

May 7, 2019
·
3 min read
Business

ADURO Teams With Bon Secours Mercy Health To Accelerate The Connection Between Well-Being And Precision Care For Modernized Healthcare

ADURO’s Digital Platform Connects the Well-being and Clinical Care Experience for Employees, Patients and Community

May 7, 2019
·
4 min read
Job Trends

The Denver Post Names Syncroness Top 50 Winner of the Colorado Top Workplaces 2019 Award

Syncroness has been ranked in the Top 50 of Top Workplaces 2019 award by The Denver Post.

May 7, 2019
·
2 min read
Business

Sigilon Therapeutics Appoints Veteran Biotech Industry Leader John Cox to Board of Directors

Sigilon Therapeutics announced the appointment of distinguished biopharma executive John Cox, MBA, to its Board of Directors.

May 7, 2019
·
2 min read
Policy

Vizient Expresses Concern with FDA Policy on Naming of Biologic Medications

Vizient, Inc. submitted comments to the Food and Drug Administration in response to its published draft guidance on the nonproprietary naming of biological products.

May 7, 2019
·
2 min read
Genetown

Verve Therapeutics Founded to Protect Against Heart Disease Launches with $58.5 Million in Series A Funding Led by GV

Company to Develop Gene Editing Therapies to Permanently Reduce Risk of Coronary Artery Disease in Adults

May 7, 2019
·
10 min read
Business

Regeneron Reports First Quarter 2019 Financial and Operating Results

Regeneron Pharmaceuticals, Inc. announced financial results for the first quarter of 2019 and provided a business update.

May 7, 2019
·
18 min read
Business

Algiax Pharmaceuticals Announces New Executive Team and Clinical Trial Plan for Lead Candidate AP-325

Algiax Pharmaceuticals Appoints Dr. Ingo Lehrke and Dr. Guido Koopmans as CEO and CSO. A Proof-of-Concept Study for Neuropathic Pain is planned to start in Q4 2019.

May 7, 2019
·
2 min read